nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—CDH5—epithelium—membranous glomerulonephritis	0.241	0.262	CbGeAlD
Lenalidomide—CDH5—cortex of kidney—membranous glomerulonephritis	0.211	0.229	CbGeAlD
Lenalidomide—CRBN—nephron tubule—membranous glomerulonephritis	0.156	0.17	CbGeAlD
Lenalidomide—CRBN—cortex of kidney—membranous glomerulonephritis	0.134	0.146	CbGeAlD
Lenalidomide—PTGS2—epithelium—membranous glomerulonephritis	0.0417	0.0454	CbGeAlD
Lenalidomide—PTGS2—kidney—membranous glomerulonephritis	0.0374	0.0407	CbGeAlD
Lenalidomide—ABCB1—nephron tubule—membranous glomerulonephritis	0.0264	0.0287	CbGeAlD
Lenalidomide—ABCB1—epithelium—membranous glomerulonephritis	0.0258	0.0281	CbGeAlD
Lenalidomide—ABCB1—kidney—membranous glomerulonephritis	0.0232	0.0252	CbGeAlD
Lenalidomide—ABCB1—cortex of kidney—membranous glomerulonephritis	0.0226	0.0245	CbGeAlD
Lenalidomide—CDH5—Cell-Cell communication—NPHS1—membranous glomerulonephritis	0.0127	0.157	CbGpPWpGaD
Lenalidomide—CDH5—S1P2 pathway—RHOA—membranous glomerulonephritis	0.0102	0.127	CbGpPWpGaD
Lenalidomide—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—TBXAS1—membranous glomerulonephritis	0.00791	0.0982	CbGpPWpGaD
Lenalidomide—PTGS2—Eicosanoid Synthesis—TBXAS1—membranous glomerulonephritis	0.00514	0.0638	CbGpPWpGaD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—RHOA—membranous glomerulonephritis	0.00473	0.0588	CbGpPWpGaD
Lenalidomide—PTGS2—Prostaglandin Synthesis and Regulation—TBXAS1—membranous glomerulonephritis	0.0043	0.0534	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—RHOA—membranous glomerulonephritis	0.00329	0.0409	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—RHOA—membranous glomerulonephritis	0.00311	0.0386	CbGpPWpGaD
Lenalidomide—PTGS2—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.00286	0.0355	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00283	0.0352	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—membranous glomerulonephritis	0.00203	0.0252	CbGpPWpGaD
Lenalidomide—PTGS2—S1P1 pathway—RHOA—membranous glomerulonephritis	0.00177	0.022	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.00158	0.0197	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—membranous glomerulonephritis	0.00131	0.0163	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ABCA1—membranous glomerulonephritis	0.00104	0.013	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—LRP2—membranous glomerulonephritis	0.001	0.0125	CbGpPWpGaD
Lenalidomide—ABCB1—ABC-family proteins mediated transport—APOA1—membranous glomerulonephritis	0.000983	0.0122	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—PLG—membranous glomerulonephritis	0.00097	0.0121	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD40—membranous glomerulonephritis	0.000841	0.0105	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DQA1—membranous glomerulonephritis	0.00073	0.00907	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.000678	0.00843	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD40LG—membranous glomerulonephritis	0.000645	0.00801	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PLG—membranous glomerulonephritis	0.000601	0.00747	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—C3—membranous glomerulonephritis	0.00057	0.00708	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ALB—membranous glomerulonephritis	0.000537	0.00668	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DRB1—membranous glomerulonephritis	0.000519	0.00645	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—C3—membranous glomerulonephritis	0.000457	0.00568	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.000437	0.00544	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—APOE—membranous glomerulonephritis	0.000426	0.00529	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000421	0.00523	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—RHOA—membranous glomerulonephritis	0.000411	0.00511	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000408	0.00507	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000364	0.00452	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00035	0.00435	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—membranous glomerulonephritis	0.000346	0.0043	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—membranous glomerulonephritis	0.000338	0.0042	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—membranous glomerulonephritis	0.000326	0.00405	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000322	0.004	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000256	0.00318	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000234	0.00291	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LRP2—membranous glomerulonephritis	0.000193	0.0024	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TBXAS1—membranous glomerulonephritis	0.000182	0.00226	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LRP2—membranous glomerulonephritis	0.000162	0.00201	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000156	0.00194	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000154	0.00192	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000152	0.00189	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000147	0.00183	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TBXAS1—membranous glomerulonephritis	0.000129	0.0016	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000121	0.0015	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LRP2—membranous glomerulonephritis	0.000115	0.00143	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000111	0.00137	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCA1—membranous glomerulonephritis	0.000104	0.0013	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000103	0.00128	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOE—membranous glomerulonephritis	8.2e-05	0.00102	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	8.14e-05	0.00101	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOA1—membranous glomerulonephritis	8.1e-05	0.00101	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ABCA1—membranous glomerulonephritis	7.4e-05	0.000919	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOE—membranous glomerulonephritis	6.87e-05	0.000853	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA1—membranous glomerulonephritis	6.79e-05	0.000843	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RHOA—membranous glomerulonephritis	6.21e-05	0.000771	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—membranous glomerulonephritis	5.38e-05	0.000668	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOE—membranous glomerulonephritis	4.87e-05	0.000605	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA1—membranous glomerulonephritis	4.81e-05	0.000598	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—membranous glomerulonephritis	3.81e-05	0.000474	CbGpPWpGaD
